Abstract
Objective: The purpose of this study was to observe if luteolin could affect the behavior of cardiac fibroblasts (CFs) on myocardial fibrosis stimulated by angiotensin II (Ang II) and investigate the mechanism involved. Methods: MTT was used to observe the CFs viability and proliferation which was also detected by an EdU staining kit. Cell migration was determined by the transwell chamber. Western blotting was used to examine the protein expression levels of a smooth muscle actin (α -SMA), collagen I and collagen III. The activity of nitric oxide (NO), synthase (NOS), nitrite and cyclic GMP (cGMP) content were measured according to the kits and an enzyme linked immunosorbent assay (ELISA) respectively. Results: The proliferation, migration and expression of α-SMA, collagen I and collagen III in CFs stimulated by Ang II were inhibited by luteolin treatment, and these effects were partly blocked by a combination of treatment with Ang II and NG-nitro-Larginine methyl ester (L-NAME), a non-selective NOS inhibitor, also with 1H-[1,2,4]-oxadiazole -[4,3-a]-quinoxalin-1- one (ODQ), a specific inhibitor of guanylyl cyclase. These effects did not include CFs migration, which showed no apparent difference between Ang II single and together with inhibitors. Luteolin increased the synthesis of total NOS and the content of nitrite and cGMP. Conclusion: These results demonstrate that luteolin is capable of inhibiting the behavior of CFs stimulated by Ang II via up-regulation of NO-cGMP signal pathway.
Keywords: Angiotensin II, cardiac fibroblast, cGMP, fibrosis, luteolin, nitric oxide.
Current Pharmaceutical Biotechnology
Title:Luteolin Antagonizes Angiotensin II-Dependent Proliferation and Collagen Synthesis of Cultured rat Cardiac Fibroblasts
Volume: 16 Issue: 5
Author(s): Tingting Wang, Defeng Pan, Yingying Zhang, Dongye Li, Yanbin Zhang, Tongda Xu, Yuanyuan Luo and Yanfeng Ma
Affiliation:
Keywords: Angiotensin II, cardiac fibroblast, cGMP, fibrosis, luteolin, nitric oxide.
Abstract: Objective: The purpose of this study was to observe if luteolin could affect the behavior of cardiac fibroblasts (CFs) on myocardial fibrosis stimulated by angiotensin II (Ang II) and investigate the mechanism involved. Methods: MTT was used to observe the CFs viability and proliferation which was also detected by an EdU staining kit. Cell migration was determined by the transwell chamber. Western blotting was used to examine the protein expression levels of a smooth muscle actin (α -SMA), collagen I and collagen III. The activity of nitric oxide (NO), synthase (NOS), nitrite and cyclic GMP (cGMP) content were measured according to the kits and an enzyme linked immunosorbent assay (ELISA) respectively. Results: The proliferation, migration and expression of α-SMA, collagen I and collagen III in CFs stimulated by Ang II were inhibited by luteolin treatment, and these effects were partly blocked by a combination of treatment with Ang II and NG-nitro-Larginine methyl ester (L-NAME), a non-selective NOS inhibitor, also with 1H-[1,2,4]-oxadiazole -[4,3-a]-quinoxalin-1- one (ODQ), a specific inhibitor of guanylyl cyclase. These effects did not include CFs migration, which showed no apparent difference between Ang II single and together with inhibitors. Luteolin increased the synthesis of total NOS and the content of nitrite and cGMP. Conclusion: These results demonstrate that luteolin is capable of inhibiting the behavior of CFs stimulated by Ang II via up-regulation of NO-cGMP signal pathway.
Export Options
About this article
Cite this article as:
Wang Tingting, Pan Defeng, Zhang Yingying, Li Dongye, Zhang Yanbin, Xu Tongda, Luo Yuanyuan and Ma Yanfeng, Luteolin Antagonizes Angiotensin II-Dependent Proliferation and Collagen Synthesis of Cultured rat Cardiac Fibroblasts, Current Pharmaceutical Biotechnology 2015; 16 (5) . https://dx.doi.org/10.2174/1389201015666141110142402
DOI https://dx.doi.org/10.2174/1389201015666141110142402 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
Call for Papers in Thematic Issues
Artificial Intelligence in Bioinformatics
Bioinformatics is an interdisciplinary field that analyzes and explores biological data. This field combines biology and information system. Artificial Intelligence (AI) has attracted great attention as it tries to replicate human intelligence. It has become common technology for analyzing and solving complex data and problems and encompasses sub-fields of machine ...read more
Latest Advancements in Biotherapeutics
The scope of this thematic issue is to comprehensively explore the rapidly evolving landscape of biotherapeutics, emphasizing breakthroughs in precision medicine. Encompassing diverse therapeutic modalities, the issue will delve into the latest developments in monoclonal antibodies, CRISPR/Cas gene editing, CAR-T cell therapies, and innovative drug delivery systems, such as nanoparticle-based ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Synthesis, Docking and Antidiabetic Activity of Some Newer Benzamide Derivatives as Potential Glucokinase Activators
Letters in Drug Design & Discovery New Insights into the Role of FGF-23 and Klotho in Cardiovascular Disease in Chronic Kidney Disease Patients
Current Vascular Pharmacology Pathogenesis and Clinical Features of Obesity and Insulin Resistance
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Long Non-Coding RNA GAS5 in Age-Related Diseases
Current Medicinal Chemistry Aging and Remodeling During Healing of the Wounded Heart: Current Therapies and Novel Drug Targets
Current Drug Targets Oxidative Stress and Drugs of Abuse: An Update
Mini-Reviews in Organic Chemistry Bridging the Gap: The Potential Role of Corticosteroid Binding Globulin in Cardiac Steroid Facilitation
Current Drug Targets Cardiotonic Steroids, Hypertension and Cardiovascular Disease
Current Hypertension Reviews Fitness or Fatness: The Debate Continues for AMP-Activated Protein Kinase in Heart Function
Current Cardiology Reviews Challenges and Opportunities from Basic Cancer Biology for Nanomedicine for Targeted Drug Delivery
Current Cancer Drug Targets Mitochondrial Dysfunction and Endoplasmic Reticulum Stress in Diabetes
Current Pharmaceutical Design Endothelial Dysfunction in Metabolic Diseases: Role of Oxidation and Possible Therapeutic Employment of N-acetylcysteine
Current Medicinal Chemistry New Chemotherapeutic Strategies Against Malaria, Leishmaniasis and Trypanosomiases
Current Medicinal Chemistry Editorial (Thematic Issue: Managing Strategies for Diverse Diseases: Challenges from Bench to Bedside Translation in Successful Drug Discovery and Dev elopment (Part C))
Current Pharmaceutical Design Patent Selections:
Recent Patents on Drug Delivery & Formulation Biomarkers of Atrial Fibrillation in Hypertension
Current Medicinal Chemistry Thiopurine Biotransformation and Pharmacological Effects: Contribution of Oxidative Stress
Current Drug Metabolism Potential of Sulphur-containing Amino Acids in the Prevention of Catecholamine-induced Arrhythmias
Current Medicinal Chemistry Mst1: Function and Mechanism in Brain and Myocardial Ischemia Reperfusion Injury
Current Neuropharmacology Potential Therapeutic Benefits of Sodium-Glucose Cotransporter 2 Inhibitors in the Context of Ischemic Heart Failure: A State-of-the-Art Review
Cardiovascular & Hematological Agents in Medicinal Chemistry